Genetic and clinical studies on 19 families with adenine phosphoribosyltransferase deficiencies
- PMID: 3817810
- DOI: 10.1007/BF00591080
Genetic and clinical studies on 19 families with adenine phosphoribosyltransferase deficiencies
Abstract
Adenine phosphoribosyltransferase (APRT) deficiency leading to 2,8-dihydroxyadenine (DHA) urolithiasis has been considered a rare cause of urolithiasis and renal insufficiency. We have examined samples from 19 Japanese families with DHA lithiasis. In 79% of the families, patients only partially lacked hemolysate APRT activities, clearly contrasting with the complete deficiency in all the patients from non-Japanese families so far reported. All patients with DHA lithiasis were homozygotes for defective APRT genes, whether the deficiency was complete or partial. In family studies we found two symptomatic and four asymptomatic homozygous family members. The segregation figures are compatible with the hypothesis of a simple autosomal recessive mode of inheritance. By analyzing the data stored by a large clinical laboratory in Japan, we estimated that 0.00368% of the general population has DHA lithiasis. These data indicate that more than 1% of the general population possess mutant alleles of the APRT gene as heterozygotes. Our present studies indicate that most of the patients with this disease are undiagnosed in Japan, and probably in other countries also.
Similar articles
-
Common characteristics of mutant adenine phosphoribosyltransferases from four separate Japanese families with 2,8-dihydroxyadenine urolithiasis associated with partial enzyme deficiencies.Hum Genet. 1985;71(2):171-6. doi: 10.1007/BF00283377. Hum Genet. 1985. PMID: 3876264
-
A case of a compound heterozygote for adenine phosphoribosyltransferase deficiency (APRT*J/APRT*Q0) leading to 2,8-dihydroxyadenine urolithiasis: review of the reported cases with 2,8-dihydroxyadenine stones in Japan.J Urol. 1993 Apr;149(4):824-6. doi: 10.1016/s0022-5347(17)36222-5. J Urol. 1993. PMID: 8455250 Review.
-
Distribution of patients with 2,8-dihydroxyadenine urolithiasis and adenine phosphoribosyltransferase deficiency in Japan.J Urol. 1988 Dec;140(6):1470-2. doi: 10.1016/s0022-5347(17)42075-1. J Urol. 1988. PMID: 3193517
-
Partial and complete adenine phosphoribosyltransferase deficiency associated with 2,8-dihydroxyadenine urolithiasis: kinetic and immunochemical properties of APRT.Enzyme. 1987;37(4):182-8. doi: 10.1159/000469260. Enzyme. 1987. PMID: 2440671
-
[Adenine phosphoribosyltransferase(APRT) deficiency].Nihon Rinsho. 1996 Dec;54(12):3321-7. Nihon Rinsho. 1996. PMID: 8976113 Review. Japanese.
Cited by
-
Genetics of kidney stone disease.Nat Rev Urol. 2020 Jul;17(7):407-421. doi: 10.1038/s41585-020-0332-x. Epub 2020 Jun 12. Nat Rev Urol. 2020. PMID: 32533118 Review.
-
Early Recognition and Management of Rare Kidney Stone Disorders.Urol Nurs. 2017 Mar-Apr;37(2):81-9, 102. Urol Nurs. 2017. PMID: 29240373 Free PMC article.
-
Adenine phosphoribosyltransferase (APRT) deficiency: an increasingly recognized disease.Int Urol Nephrol. 2025 Aug;57(8):2519-2529. doi: 10.1007/s11255-025-04420-6. Epub 2025 Feb 21. Int Urol Nephrol. 2025. PMID: 39982660 Review.
-
Purine enzyme defects as a cause of acute renal failure in childhood.Pediatr Nephrol. 1989 Oct;3(4):433-7. doi: 10.1007/BF00850222. Pediatr Nephrol. 1989. PMID: 2642113
-
Recurrent 2,8-dihydroxyadenine nephropathy: a rare but preventable cause of renal allograft failure.Am J Transplant. 2014 Nov;14(11):2623-32. doi: 10.1111/ajt.12926. Epub 2014 Oct 10. Am J Transplant. 2014. PMID: 25307253 Free PMC article.